EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir

Joanna E Jones iD, Chelsea E Gunderson, Brian Wigdahl iD, Michael R Nonnemacher

Viruses · 2026

DOI: 10.3390/v18030354 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2026. Verfasst von Joanna E Jones und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, USA. Hauptthemen laut MEDLINE: HIV-1, Epigenesis, Genetic, Virus Latency, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 431 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health, NIMH Comprehensive NeuroHIV Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human immunodeficiency virus type 1 (HIV-1) is a retrovirus that integrates into the host cell’s DNA as a provirus. Transcription from the provirus is regulated in large part by cellular proteins and epigenetic factors. These may be repressive or permissive to productive infection. The host factors that regulate this balance are therefore attractive targets for HIV-1 therapeutics. Indeed, proviral chromatin is the focus of two of the current HIV-1 cure strategies. “Shock and Kill” uses latency reversal agents to open the provirus’s chromatin, promoting high levels of gene expression that induce the killing of infected cells. “Block and Lock” uses latency promoting agents to induce heterochromatin, blocking transcription and forcing HIV-1 into a state of deep latency. Here, the compounds investigated in both strategies are reviewed, including their chemical structures, mechanisms of action, and clinical results. Finally, the use of CRISPR-Cas therapeutics and the impact of chromatin architecture on its efficacy are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Epigenesis, GeneticVirus LatencyHIV InfectionsAnti-HIV AgentsHumansProvirusesChromatinGene Expression Regulation, ViralCRISPR-Cas SystemsVirus Integration

Stichwörter der Autor:innen

HIV-1HIV-1 curechromatinepigenetic modifierssmall molecules

Substanzen

ChromatinAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
  • Center for Molecular Virology and Gene Therapy, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
  • Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

ORCID-Profile: Joanna E Jones, Brian Wigdahl

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health
  • NIMH Comprehensive NeuroHIV Center
  • Ruth L. Kirschstein National Research Service Award

Zitieren

APA

Jones, J. E., Gunderson, C. E., Wigdahl, B., & Nonnemacher, M. R. (2026). Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir. Viruses. https://doi.org/10.3390/v18030354

Vancouver

Jones JE, Gunderson CE, Wigdahl B, Nonnemacher MR. Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir. Viruses. 2026. doi:10.3390/v18030354

BibTeX
@article{Jones2026,
  author = {Jones, Joanna E and Gunderson, Chelsea E and Wigdahl, Brian and Nonnemacher, Michael R},
  title = {Breaking into HIV-1’s Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18030354}
}
Kostenlos starten →